Diagnosis and therapeutic strategies for hepatopulmonary syndrome
10.3760/cma.j.cn501113-20200424-00211
- VernacularTitle:肝肺综合征的诊治对策
- Author:
Junjun CAI
1
;
Qian ZHANG
;
Tao HAN
Author Information
1. 天津市第三中心医院肝内科 天津市人工细胞重点实验室 天津市肝胆疾病研究所 300170
- Keywords:
Liver cirrhosis;
Hepatopulmonary syndrome;
Portal hypertension;
Intrapulmonary vascular dilatations;
Liver transplantation
- From:
Chinese Journal of Hepatology
2020;28(5):386-390
- CountryChina
- Language:Chinese
-
Abstract:
Hepatopulmonary syndrome (HPS) is a common pulmonary complication in patients with liver disease and / or portal hypertension, and is characterized by abnormal arterial oxygenation caused by intrapulmonary vascular dilatation. The pathogenesis of HPS is complex, with a low clinical early diagnosis rate and poor prognosis. HPS currently lacks effective therapeutic drugs; therefore, liver transplantation is the only fundamental treatment. This article summarizes the pathogenesis, clinical manifestations, diagnosis and treatment of HPS in order to further improve the level of clinical screening and diagnosis and treatment of HPS.
